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Abstract
Background: Malaria represents a huge burden for the health care services across Africa. Describing malaria attending health
services contributes to quantify the burden and describe the epidemiology and clinical presentation.
Methods: Retrospective analysis of data collected through the Manhiça morbidity surveillance system (Mozambique) on all
paediatric visits (<15 years) to the outpatient clinic from June 2003 to May 2005. Age-specific minimum community-based
incidence rates (MCBIRs) of malaria were calculated using demographic surveillance system data. Malaria was defined as fever
or history of fever in the preceding 24 hours with asexual Plasmodium falciparum parasitaemia of any density in the blood smear.
Results: A total of 94,941 outpatient visits were seen during the study period, of which 30.5% had malaria. Children younger
than three years accounted for almost half of the total malaria cases and children aged ≥ 5 years represented 36.4% of the cases.
Among children who presented with malaria, 56.7% had fever and among children who presented with fever or a history of fever
only 37.2% had malaria. The geometric mean parasitaemia in malaria cases was 8582.2 parasites/μL, peaking in children aged two
to three years. 13% of malaria cases had a PCV<25% and the mean PCV in malaria cases increased gradually with age, ranging
from 27.8% in children aged 2–12 months to 34.4% in ≥ 5 years. The percentage of cases admitted or transferred showed a clear
decreasing trend with age. MCBIRs of outpatient malaria per 1,000 child years at risk for the whole study period were of 394
in infants, 630 in children aged 1 to <5 years and 237 in children aged five years or more. A clustering of the cases was observed,
whereby most children never had malaria, some had a few episodes and very few had many episodes.
Conclusion: Preventive measures should be targeted at children younger than three years, as they carry the highest burden of
malaria. Children aged 5–15 years represent around a third of the malaria cases and should also be included in control
programmes. Concern should be raised about presumptive treatment of fever cases with artemisinin-combination therapies, as
many children will, according to IMCI guidelines, receive treatment unnecessarily.
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Background
Malaria continues to be the first single cause of mortality
in children in sub-Saharan Africa [1] and a major obstacle
for the economic development in many countries [2].
Moreover, malaria represents between 25 and 40% of all
outpatient visits to health centres in African malaria-
endemic countries [1]. It is critical that control pro-
grammes implement available cost-effective control tools
to decrease the burden of disease, especially among young
children and pregnant women.
In Mozambique, as in most sub-Saharan African coun-
tries, the health management information system is weak
[3]. Therefore, the Ministry of Health has incomplete and
inaccurate data on the burden of disease of a given pathol-
ogy, making it difficult for managers to develop evidence-
based health policies. Also, few studies have been pub-
lished on the malaria epidemiology in the country [4-7].
It is crucial that data on the incidence and age distribution
of malaria is made available and is used to define and
assess control programmes. Hospital surveillance data,
despite being influenced by health-seeking behaviour and
accessibility, are a valuable and often the only source of
information on the most prevalent health problems of a
community and their epidemiology.
Data are presented on the characteristics of malaria in
children who attend the outpatient clinic of a rural hospi-
tal and minimum community-based incidence rates in a
rural area of southern Mozambique. Data on children
with malaria admitted to the same hospital are presented
in a companion article [8].
Methods
Study site and population
The study area is located in Manhiça, Maputo Province,
southern Mozambique. The area has been described in
detail elsewhere [9]. There are two different seasons: a
warm and rainy season and a cool dry season. The mean
annual temperature is 22.5°C, ranging from a mean tem-
perature of 25.5°C in January to 18.3°C in July. The
annual rainfall was of 1286 mm in the year 2003, of 1165
mm in 2004 and of 687 in 2005.
Malaria transmission in the area, mainly caused by Plas-
modium falciparum, is perennial with substantial seasonal-
ity and of moderate intensity. The average entomological
inoculation rate (EIR) was of 38 infective bites per person
per year in 2002, being Anopheles funestus the main vector
[10,11].
Malaria control in the area is based on prompt treatment
of cases, the coverage of insecticide-treated nets being
<10% throughout the study period. The Manhiça District
Hospital is the main health facility in the area, used for
primary health care by the nearby population, and one of
the two referral health centres for Manhiça District. It has
a 110-bed inpatient ward, an outpatient clinic, a maternal
and child health clinic with a small surgical room, and an
emergency room [12]. There are two other peripheral
health posts in the area, used only for primary health care.
Both the hospital and the health posts are easily accessible
and all outpatient consultations are free, except for a
standard subsidized fee for the outpatient medication to
be taken home.
The Manhiça Health Research Center (Centro de Investi-
gação em Saúde de Manhiça, CISM) runs since 1996 a
Demographic Surveillance System in the area [9] and a
morbidity surveillance system at Manhiça District Hospi-
tal and other peripheral health posts in the area, including
the Maragra Health Post, 20 km south of Manhiça District
Hospital. The DSS covers Manhiça town and the sur-
rounding villages, the Manhiça study area, with a total
population under surveillance of around 80,000 inhabit-
ants, 44% of which are under 15 years of age. The infant-
mortality rate in the study area in 2005 was 77.5 per 1,000
live births, and the under-five mortality rate was 138.6 per
1,000 [13]. All children resident in the study area have a
card with a permanent identification number issued by
the DSS.
Study design
Retrospective analysis of data collected through the Man-
hiça morbidity surveillance system. All paediatric visits
(<15 years) to the outpatient clinic from 1st of June 2003
to 31st of May 2005 were analysed.
Hospital surveillance system
A passive case detection system was established in 1996 to
cover all paediatric (children aged 0–<15 years) outpa-
tient and inpatient visits to Manhiça District Hospital and
all outpatient visits to the Maragra Health Post. A stand-
ardized questionnaire, which includes personal and
demographic data (including the permanent identifica-
tion number) and clinical signs and symptoms, is com-
pleted for each child seen at the outpatient clinic. The
clinician on duty, usually a medical agent (medical agents
receive a clinical training of at least two years after second-
ary school), records the physical signs found on examina-
tion and the symptoms and duration of those as referred
by the child's guardian. The axillary temperature is taken
with an electronic thermometer and a finger-prick blood
sample is collected from children who present fever (axil-
lary temperature ≥ 37.5°C) or report a history of fever in
the preceding 24 hours. Blood is collected into
heparinized capillaries to measure the packed cell volume
(PCV) and thin and thick blood smears are prepared to
determine parasitaemia. Final diagnosis/es are recorded
on the questionnaire by the clinician upon discharge orMalaria Journal 2008, 7:36 http://www.malariajournal.com/content/7/1/36
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admission to the ward, after review of all signs, symptoms
and laboratory results.
Case management
Children seen at the outpatient clinic of Manhiça District
Hospital are either sent home after diagnosis and treat-
ment, or, if they fulfill severity criteria, are referred to the
day-care unit of the hospital. The day-care unit was cre-
ated by CISM to operate as an intermediate step between
the outpatient clinic and the paediatric ward. Children
seen at the outpatient clinic who fulfill severity criteria or
need close monitoring are referred to the day-care unit,
where they are reassessed by a more senior clinician, sta-
bilized, and they receive initial treatment. This unit only
works during the day and before it closes all children are
either discharged, after a final diagnosis and treatment, or
admitted to the wards. The referral hospital for Manhiça is
the Maputo Central Hospital, where some of the children
are transferred, being the unavailability of blood for trans-
fusion the main reason.
Children seen at the Maragra Health Post fulfilling sever-
ity criteria are transferred to the Manhiça District Hospital,
where they follow the standard circuit. Malaria cases were
treated according to the Mozambican national guidelines.
The first line treatment for ambulatory patients was chlo-
roquine until it was changed in 2003 to sulphadoxine-
pyrimethamine (SP) plus amodiaquine (AQ). In 2006 it
was changed again to SP plus artesunate. During the study
period the first line treatment was SP+AQ (parasitological
efficacy was 92% in 2001–02 in Manhiça [14]) and Co-
Artem® was the second line treatment. Patients who were
referred to the day-care unit and later to the wards
received parenteral quinine for a minimum of six doses,
followed by SP, or continued up to 21 doses if given as
monotherapy.
Laboratory methods
The PCV was measured using a microhaematocrit centri-
fuge and a Hawksley reader (Hawksley & Sons Ltd, Lanc-
ing, UK). Thin and thick blood films were read to quantify
parasitaemia in the CISM laboratory according to stand-
ard procedures. Blood films were air-dried, Giemsa-
stained, and examined using a light microscope fitted
with a 10× oil immersion lens. Slides were declared nega-
tive only after 2000 leukocytes have been counted. Para-
site numbers were converted to a count/μL by assuming a
standard leukocyte count of 8000/μL.
Definitions
Malaria was defined as fever (axillary temperature of ≥
37.5°C) or a history of fever in the preceding 24 hours
plus a P. falciparum asexual parasitaemia of any density.
No age cut-off for the level of parasitaemia was used to
increase the specificity of the definition, as this is the def-
inition used at the outpatient clinic for all ages to diag-
nose malaria and administer antimalarials.
Mild anaemia was defined as a PCV between 25% and
<33%, moderate anaemia as a PCV 15% to <25% and
severe anaemia as a PCV<15%. Hyperpyrexia was defined
as a measured axillary temperature of ≥ 39°C. The rainy
season was defined as November to April and the dry sea-
son as May to October.
Data management and statistical methods
Questionnaires were double entered into databases using
a programme written in Fox Pro (Microsoft Corp., Seattle,
WA, USA) at CISM. Statistical analyses were performed
using Stata 9 (Stata Corp., College Station, TX, USA). The
DSS permanent identification number, which is recorded
on the morbidity questionnaires when children attend the
hospital, was used to classify children as residents/non-
residents in the study area. Occasionally, the mother/
accompanying person fails to show the card when attend-
ing the hospital and the number is not recorded, thus the
number of outpatient visits of children from the study
area are underestimates.
Minimum community-based incidence rates (MCBIRs)
were calculated as the age-specific yearly number of
malaria cases visited at the outpatient clinic in children
resident in the study area divided by the total child years
at risk (CYAR) for that age group and year. CYAR were esti-
mated from the DSS databases and children did not con-
tribute to the numerator or denominator for a period of
28 days after each episode of malaria, when they were out-
side the study area or after death. Rate ratios and their p-
values were estimated using the Mantel-Haenzel method
to compare age-specific and year-specific rates.
Qualitative variables were compared using a χ2 test or
Fisher's exact test. Means of normally distributed variables
were compared using the Student's t-test or ANOVA.
Geometric means of parasitaemia were compared using
the Wilcoxon Rank sum test.
Parasitaemia results were missing for 1.8% and PCV
results for 1.5% of the outpatients who had fever or a his-
tory of fever. Age was missing in 0.2% of the outpatients.
Results
A total of 94,940 visits were seen at the outpatient clinic
of Manhiça District Hospital and Maragra Health Post
during the two year study period. Of these, 30.5%
(28,963) had malaria, ranging from 34.1% in the first year
of surveillance to 26.5% in the second year. Males
accounted for 50.5% of the malaria cases.Malaria Journal 2008, 7:36 http://www.malariajournal.com/content/7/1/36
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The age distribution of malaria cases is shown in Figure 1.
Children younger than three years accounted for almost
half of the total malaria cases, the highest number of cases
being in children in their second year of life. Children
aged five years or older represented 36.4% of the total
malaria cases. Figure 2 shows the contribution of malaria
to the total outpatient visits in each age group. Malaria
accounted for almost 40% of the outpatient visits in chil-
dren aged two years or older, but this percentage was
lower in the first two years of life, during which it
increased gradually with age.
Figure 3 presents the seasonality of malaria cases and the
rainfall recorded. Sixty-three percent of the malaria cases
occurred during the six months of rainy season (p <
0.0001), peaking in December each year, and the percent-
age of outpatient visits due to malaria was higher during
the rainy than the dry season (32.0% vs. 29.4%, χ2(1 d.f.)
= 69.5, p < 0.0001).
Table 1 summarizes the clinical characteristics of children
with malaria presenting at the outpatient clinic. Among
children who presented with malaria 56.7% had fever and
24.2% had hyperpyrexia. The median of reported days of
fever was significantly higher in children who were trans-
ferred to the day-care unit (2 days, IQR 1–3 days) than
among those who were sent home after being visited at
the outpatient clinic (1 day, IQR 1–2 days, p < 0.0001).
Children resident in the study area also had a shorter
duration of reported fever (1 day, IQR 1–2 days) than
children from outside the study area (2 days, IQR 1–3
days, p < 0.0001). On the other hand, only 37.2% of chil-
dren with fever or a reported history of fever during the
previous 24 hours had malaria parasites and were there-
fore diagnosed as malaria cases. Among those who pre-
sented with fever this percentage was 47.8% and among
those who were afebrile on arrival but reported fever it
was 21.2%.
The geometric mean parasitaemia (GMP) increased with
age during the first three years of life, peaking in children
aged two to three years and then decreased gradually with
age. Figure 4 shows the GMP and the mean PCV in
malaria and non-malaria cases by age, including only chil-
dren aged older than two months. The GMP in malaria
cases was 8,582.2 parasites/μL, being significantly higher
in children with fever (13,989.7) than in afebrile children
(4,529.4, p < 0.0001) and in children with hyperpyrexia
(24,003.3) than in those with a fever lower than 39°C
(9,349.7, p < 0.0001). It was also higher among children
transferred to the day-care unit (12,648.7) than among
children sent home directly after being visited at the out-
patient clinic (7,292.1, p < 0.0001). Among children
transferred to the day-care unit, it was higher in children
finally admitted to the wards (15,510.0) than in children
sent home (9,860.3, p < 0.0001). GMPs were also higher
during the rainy season (9,627.3) than during the dry sea-
son (7,074.5, p < 0.0001).
Seasonality of outpatient malaria visits and rainfall (mm) Figure 3
Seasonality of outpatient malaria visits and rainfall 
(mm).
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Age distribution of outpatient malaria cases Figure 1
Age distribution of outpatient malaria cases.
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More than half of the malaria patients were anaemic,
11.9% had moderate anaemia, compared to 2.0% of the
non-malaria cases (χ2(1 d.f.) = 3277.2, p < 0.0001), and
0.9% had severe anaemia, compared to 0.1% of the non-
malaria cases (χ2(1 d.f.) = 242.1, p < 0.0001). The mean
PCV was significantly lower in malaria cases (31.2%, SD
6.0) than in non-malaria cases (34.4%, SD 4.8, p <
0.0001). The mean PCV increased gradually with age both
in malaria and non-malaria cases, although the increase
was greater among malaria cases, in which the PCV ranged
from 27.8% in infants aged 2 to 12 months to 34.4% in
children aged 5 years or older (p < 0.0001 ANOVA and
linear regression). The mean PCV difference between
malaria and non-malaria cases was 4.9% (95% CI
4.7–5.1) in infants and 1.8% (95% CI 1.7–1.9) in chil-
dren aged five years or above. The prevalence of moderate
and severe anaemia presented no seasonality, being the
same during the rainy and dry seasons both in malaria
and total patients, although 63% and 60% of the total
moderate and severe anaemia cases respectively occurred
during the rainy season (p < 0.001).
Among malaria patients an inverse relationship was
observed between PCV and density of parasitaemia.
Among children younger than five years, doubling the
parasitaemia was associated with a decrease in the mean
of PCV of 0.14 units (%) on average, while among chil-
dren aged five years or older, this decrease was of 0.07
units (p < 0.0001 linear regression, for both age groups).
Table 2 presents the outcome of outpatient malaria cases
by age. Among children with malaria, 28.1% were trans-
ferred to the day-care unit, and of these 54.1% were finally
admitted to the ward. These percentages and the percent-
age of children transferred to Maputo Central Hospital
show a clear decreasing trend with age (p < 0.0001, test for
trend). Overall, infants with malaria were admitted in a
significantly higher proportion than children aged 1–4
years (33.4% vs. 19.0%; χ2(1 d.f.) = 344.7, p < 0.0001).
Also, among malaria cases, children resident in the study
area were transferred to the day-care unit and then admit-
ted to the wards with a significantly lower frequency than
children from outside the study area (23.6% vs. 33.9%,
χ2(1 d.f.) = 371.7, p < 0.0001 and 45.4% vs. 62.0% of
Geometric mean parasitaemia (GMP) and mean PCV (with 95% CI) among malaria outpatients and mean PCV among non- malaria outpatients by age group Figure 4
Geometric mean parasitaemia (GMP) and mean PCV (with 95% CI) among malaria outpatients and mean 
PCV among non-malaria outpatients by age group.
Table 1: Anaemia, fever and parasitaemia among outpatient 
malaria cases
Mild anaemia (%, n/N) 41.3% (11783/28525)
Moderate anaemia (%, n/N) 11.9% (3407/28525)
Severe anaemia (%, n/N) 0.9% (249/28525)
Mean (SD) PCV 31.2 (6.0)
Axillary temperature ≥ 37.5°C (%, n/N) 56.7% (16413/93429)
Axillary temperature ≥ 39°C (%, n/N) 24.2% (7015/93429)
Median length (IQR)* of reported fever on 
arrival (days)
1 (1; 2)
Geometric mean parasitaemia (95% CI)# 
(parasites/μL)
8582.8 (8346.3–8826.0)
*IQR: interquartile range
#95% CI: 95% confidence intervalMalaria Journal 2008, 7:36 http://www.malariajournal.com/content/7/1/36
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those transferred to the day-care unit, χ2(1 d.f.) = 225.1, p
< 0.0001, respectively).
Minimum community-based incidence rates of outpatient
malaria per 1000 CYAR for the whole study period were
of 394 in infants, 630 in children aged 1 to <5 years and
237 in children aged five years and older. Table 3 presents
the age-specific MCBIRs in the Manhiça study area by
year. These incidences include only malaria cases in chil-
dren resident in the study area. Among this group, there
were 14,764 cases of malaria during the study period,
experienced by 7,365 children. More than half of these
(4,221/7,365, 57.3%) presented only once to the health
centres with an episode of malaria, 19.9% (1,464) pre-
sented twice, 9.2% (674) presented three times and the
remaining 13.6% presented four and up to a maximum of
14 times with malaria, showing a clustering of the clinical
cases in a relatively small number of children. Consider-
ing that 26,923 study area children contributed to the
time at risk, only 27.4% (7,365/26,923) of children in the
study area have attended at least once the outpatient clinic
with malaria during the two year study period. For chil-
dren aged one to four years, who account for the majority
of the malaria cases, this percentage is 33.2%.
The incidence of malaria in children aged 1 to 4 years was
significantly higher than in infants (RR 1.5 for the first
year and 1.9 for the second year of the study, p < 0.0001
for both), whereas the incidence in children aged 5 years
or older was lower than in infants (RR 0.5 for the first year
and 0.8 for the second year of the study, p < 0.0001 for
both).
The incidence in the first year of the study period was sig-
nificantly higher than that during the second year (RR 1.6,
p < 0.0001), this difference being highest in infants (RR
2.1, p < 0.0001).
Table 3: Age-specific minimum community-based incidence of clinical malaria, events per child years at risk
June 2003–May 2004 June 2004–May 2005
Age group Episodes CYAR Rate per 1000 CYAR 95% CI Episodes CYAR Rate per 1000 CYAR 95% CI
<1 month 8 155 51.7 25.9–103.4 7 153 45.8 21.9–96.2
1–<6 months 252 788 319.9 282.7–361.9 112 767 146.0 121.3–175.7
6–<12 months 700 852 821.5 762.8–884.6 334 871 383.6 344.6–427.1
1–<2 years 1490 1539 968.3 920.4–1018.8 842 1679 501.6 468.8–536.6
2–<3 years 1223 1410 867.6 820.3–917.6 899 1549 580.6 543.8–619.8
3–<4 years 1030 1435 717.6 675.1–762.8 664 1448 458.5 425.0–494.8
4–<5 years 868 1439 603.1 564.3–644.6 533 1484 359.2 330.0–391.1
5–<10 years 2279 6648 342.8 329.0–357.2 1701 6973 244.0 232.6–255.8
10–<15 years 1043 5265 198.1 186.4–210.5 779 5606 139.0 129.5–149.1
CYAR: child years at risk
95% CI: 95% confidence interval
Table 2: Outcome of outpatient malaria cases by age
After outpatient* (%) After day-care unit* (%)
Age group N Home Day-care unit Transfer** Home Admitted Transfer#
<1 month 42 35.7 61.9 2.4 42.3 53.8 0
1–<6 months 1019 40.8 55.4 3.4 32.6 62.6 4.4
6–<12 months 2450 41.7 55.3 2.7 37.1 59.3 3.2
1–<2 years 5201 51.4 46.1 2.3 38.9 57.9 2.6
2–<3 years 4203 62.5 35.6 1.6 42.7 54.6 2.3
3–<4 years 3069 72.5 26.0 1.2 47.8 50.3 1.1
4–<5 years 2383 79.6 19.8 0.5 53.6 44.9 0.8
5–<10 years 6763 87.7 11.9 0.3 59.7 39.1 0.7
10–<15 years 3747 94.0 5.6 0.1 56.4 42.7 0.5
Total 28877 70.4 28.2 1.2 43.1 54.1 2.3
*Totals do not add up to 100%, as the percentage of children who absconded or died are not presented in the table
**Transfers mostly from Maragra Health Post to Manhiça District Hospital
#Transfers mostly from Manhiça District Hospital to Maputo Central HospitalMalaria Journal 2008, 7:36 http://www.malariajournal.com/content/7/1/36
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Discussion
This paper describes the characteristics of children pre-
senting with clinical malaria to the outpatient clinic of
two health facilities in a rural area of southern Mozam-
bique. Malaria represents a huge burden for the primary
health care services, accounting for around 30% of the
total visits. This implies a considerable health service uti-
lization derived from one single disease, which is likely to
translate into a significant health expenditure.
The age distribution of the cases is typical of an area of
moderate transmission, with most of the cases occurring
in children younger than 5 years, with a peak in children
aged 1 to 2 years [15]. Despite malaria not representing a
high percentage of the total outpatient visits among chil-
dren younger than three years, this age group carries most
of the burden of disease, accounting for around half of the
total malaria cases.
The age distribution of outpatient malaria is more spread
out than that of malaria requiring admission to the wards,
as children younger than three years represent 45% of the
cases among outpatient attendees, while children younger
than two years account for 58% of the cases among admit-
ted children [8]. Interestingly, children aged 5 to 14 years
represent 36% of the malaria outpatient cases, whereas
this percentage is only 9% among malaria cases that
require admission to the hospital [8]. This supports the
hypothesis that immunity against severe malaria develops
faster than against milder forms [16], as the percentage of
children in this age group that need admission is low.
Nevertheless, it also shows that malaria in older children
and teenagers has been previously underestimated and
that malaria control programmes should also target them
[17]. Control tools that would be of use for this age group
include insecticide-treated nets, although distribution sys-
tems should be developed, and new control strategies
such as school-based intermittent preventive treatment
(IPT). Data from research conducted in Africa in the
1950s suggest that continuous chemoprophylaxis in
schoolchildren does not impair the development of natu-
rally acquired immunity and that it does not cause a
rebound effect afterwards. Nevertheless, to avoid develop-
ment of drug resistances and facilitate sustainability, inter-
mittent preventive treatment, that could be maybe
delivered at school level, would be a better option [18].
Infants, who suffer an important incidence of malaria, are
transferred to the day-care unit and admitted to the wards
with a significantly higher frequency than older children,
reflecting either a greater severity of disease in infants, a
high co-morbidity and/or a tendency of the medical staff
to admit them more easily. Malaria control strategies
should target children younger than three years, the age
group most at risk, and particularly infants, who carry a
disproportionate amount of severe disease.
Presentation of malaria cases to the outpatient clinic
showed marked seasonality, with a peak in December
each year. This seasonality is related to the actual rainfall,
but the peak in malaria cases does not always follow the
peak in the rainfall, as shown in Figure 3, suggesting there
are other factors affecting the health facility-based malaria
incidence, including health-seeking behaviour patterns.
According to the Integrated Management of Childhood
Illness, children with a measured or reported fever in high
malaria risk areas, and in the absence of facilities
equipped with a microscope, should be classified as hav-
ing malaria and receive presumptive antimalarial treat-
ment [19]. In this study, only 37% of children who
presented to the outpatient clinic with fever or a history of
fever had malaria, reflecting the low specificity of fever
(measured or reported). In a health post without a micro-
scope or rapid diagnostic tests, 63% of children would be
treated for malaria unnecessarily and probably not treated
for the underlying condition, increasing the risk of severe
disease, resistances to antimalarials and adverse effects. In
the context of artemisinin-combination therapies (ACTs),
often used presumptively as first line antimalarials, safety
issues and cost have to be taken into account, and the risk
of giving drugs unnecessarily should not be underesti-
mated. Strengthening of health services through the avail-
ability of rapid diagnostic tests or microscopic facilities is
crucial to decrease presumptive treatment and slow the
rate of development of resistances. Concerns have been
raised about the drug pressure that IPTi would exert if
implemented widely, however presumptive treatment of
malaria based on clinical symptoms (mainly presence of
fever) is probably a considerable and greater source of
drug resistance. The median duration of reported fever
was one day, showing that in this area most families do
not wait very long to go to hospital. Nevertheless children
who were transferred to the day-care unit reported a
longer, although still very short, duration of fever. This,
together with the fact that children coming from outside
the study area reported a longer duration of fever and were
transferred to the day-care unit and admitted to the wards
more frequently, reflects the fast evolution of malaria,
with severity increasing with time without treatment.
Only 57% of children with malaria presented with a
measured fever, which indicates that if measured fever was
used as the only criterion to collect a blood slide many
cases would not be detected and treated.
Parasite density was higher in admitted children, proba-
bly reflecting that high parasite levels on its own are very
often a criterion for admission, especially when childrenMalaria Journal 2008, 7:36 http://www.malariajournal.com/content/7/1/36
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are seen by a medical agent and not by a physician. Nev-
ertheless, the level of parasitaemia – although it was asso-
ciated with lower PCVs – was not found to be a risk factor
for severity of malaria neither in admitted children in this
area [8] nor elsewhere [20-22].
The decrease of parasitaemia density and the increase of
the mean PCV with age reflect the development of natu-
rally acquired immunity against malaria. The peak of the
incidence of clinical malaria is in children aged one to
three years, and coincides with the peak in parasitaemia
density, that occurs in children aged two to three years.
This argues against the widely accepted hypothesis that
anti-disease immunity is different from anti-parasite
immunity and supports the idea that actually these two
immunities are the same and develop at the same time
[23]. In an active case detection study conducted in the
area the peak parasite density was at age one year, point-
ing in the same direction [6].
More than half of malaria cases present with anaemia,
being moderate or severe in 13% of the cases. The aetiol-
ogy of anaemia in Manhiça and the relative contribution
of malaria to its development have not been determined,
but malaria appears to be an important contributor, as
children with malaria have a significantly lower PCV than
children without malaria. This difference in the mean PCV
between malaria and non-malaria cases is greater in
younger than in older children, suggesting that malaria is
a greater contributor to anaemia in infants and young
children [24]. This is in agreement with chemoprophy-
laxis and bed net studies, where it was also observed that
efficacy against anaemia was higher in younger infants
[18,25]. On the other hand, the lack of significant season-
ality of the prevalence of anaemia suggests that there are
other causes of anaemia-nutritional or other infections –
that are also present during the dry season.
The malaria MCBIR in children younger than five years
from Manhiça, 575.7 per 1,000 CYAR, is within the inter-
val of the estimated incidence rate for that age group in
Africa in 2000 for rural areas with an EIR < 100 infective
bites per person per year (414 – 1924 per 1000 CYAR)
[26]. The malaria minimum community-based incidence
rate in infants is relatively low during the first six months
of life but increases in children aged six to 11 months, and
peaks in children aged one to three years. A malaria active
case detection (ACD) study conducted in children
younger than 10 years in the study area during the period
1996–99 found a similar age pattern, with the peak inci-
dence of clinical malaria being between six months and
three years [7]. Infants in this area start experiencing
malaria very early in life. During the first year of life the
MCBIR increases with age, probably a function of a
decreased exposure to mosquitoes in small infants, the
protective effect of foetal haemoglobin in the first weeks
of life, and the presence of maternally-acquired malaria-
specific antibodies, even though the protection they con-
fer is still a matter of debate [27]. However, the almost
negligible incidence rates observed in newborns are prob-
ably underestimates of the real burden of the disease, as
newborns being born at the hospital and becoming ill are
often directly admitted from the maternity ward, and the
collection of data as well of slides through the outpatient
department may have been suboptimal during the study
period.
The MCBIRs show a 40% decrease from the first year to
the second year of the study. This reduction in the inci-
dence shifted the age distribution to the right, being this
decrease highest for infants. The rate ratio of the incidence
in children aged one to four years old versus infants was
highest in the second year. This change also illustrates the
interannual variability in malaria incidence, which can be
due to multiple reasons, discussed more thoroughly in the
second part of this article [8].
More than 70% of the study area children have never pre-
sented to the health facilities with malaria, and among
those who have, more than half had only one episode.
These results are very similar to those found during the
active case detection study, where 71% of children never
had malaria and 50% of those who did, only had one epi-
sode, and to the results of the control group of the RTS, S
malaria vaccine trial conducted in the area, where these
percentages were even higher (80.5% and 70% respec-
tively) [28]. This supports the idea that there is a clustering
of the clinical episodes, whereby many children have no
malaria, some have just a few episodes and very few have
many episodes, appearing to be at a greater inherent risk
than others.
Conclusion
This article presents a retrospective analysis of outpatient
data on malaria in children. Despite the limitations of
hospital-based data, these provide an indication of the
burden and age pattern of the disease, that may guide pol-
icy makers. Children younger than three years carry the
burden of malaria, and control strategies should be tar-
geted at them. Children between five and 15 years also
suffer an important proportion of the disease, although
less severe, and should be included in control pro-
grammes. Moreover, this would also decrease the enor-
mous toll paid by health facilities to manage this disease.
Preventive measures together with effective treatment of
correctly diagnosed cases should on the long term guaran-
tee that malaria ceases to be the number one cause of
childhood disease in Africa.Malaria Journal 2008, 7:36 http://www.malariajournal.com/content/7/1/36
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